Internal Medicine, Nephrology · Danville, PA
NPI
1437535283
Since 2015
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
100 N Academy Ave
Danville, PA, 17822
Phone (570) 271-6393
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
1,025 services
Medicare patients, 2024
288
Average age 70
Drug cost, 2024
$1.0M
1,653 prescriptions
Company payments, 2025
$85K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kartik Kalra was code 99232 (hospital e&m - subsequent), 205 times for 88 patients. In total Kartik Kalra billed 1,025 services in 21 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 205 | 88 | $58.96 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 135 | 99 | $11.26 | $1,520 |
| 99214 Office E&M - Established | Facility | 83 | 71 | $66.62 | $5,530 |
| 90960 ESRD Related Services (not dialysis) | Office | 71 | 13 | $266.03 | $19K |
| 99215 Office E&M - Established | Facility | 60 | 44 | $98.33 | $5,900 |
| 90935 Hemodialysis | Facility | 50 | 34 | $52.20 | $2,610 |
| 99222 Hospital E&M - Initial | Facility | 36 | 36 | $95.66 | $3,444 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 19 | $89.09 | $2,673 |
| 90961 ESRD Related Services (not dialysis) | Office | 30 | 15 | $215.50 | $6,465 |
| 99204 Office E&M - New | Facility | 26 | 26 | $94.00 | $2,444 |
| 99223 Hospital E&M - Initial | Facility | 25 | 25 | $127.50 | $3,187 |
By year: 2022 $97K for 911 services; 2023 $75K for 758 services; 2024 $87K for 1,025 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kartik Kalra prescribed most often to Medicare patients was Amlodipine Besylate, with 193 prescriptions and refills. In total Kartik Kalra wrote 1,653 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 193 | 471 | 69 | $1,895 |
| Torsemide Generic | 150 | 301 | 56 | $3,477 |
| Clonidine Generic | 96 | 103 | 12 | $6,759 |
| Chlorthalidone Generic | 84 | 217 | 27 | $1,155 |
| Telmisartan Generic | 83 | 174 | 36 | $2,375 |
| Losartan Potassium Generic | 81 | 163 | 27 | $1,446 |
| Lisinopril Generic | 80 | 188 | 29 | $681 |
| Telmisartan-Amlodipine Telmisartan/Amlodipine | 75 | 116 | 14 | $12K |
| Famotidine Generic | 67 | 133 | 19 | $481 |
| Carvedilol Generic | 57 | 116 | 16 | $554 |
| Atorvastatin Calcium Generic | 49 | 115 | 15 | $482 |
| Furosemide Generic | 49 | 73 | 13 | $443 |
| Potassium Chloride Generic | 46 | 100 | 17 | $1,058 |
| Calcitriol Generic | 45 | 75 | 13 | $736 |
| Jardiance Empagliflozin | 35 | 74 | 12 | $41K |
Brand drugs: 124 claims; generic drugs: 1,529 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kartik Kalra $85K ($85K in general payments such as food, travel and fees) from 8 companies. The largest payer was Otsuka Pharmaceutical Development & Commercialization, Inc. with $41K.
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 35 | $41K |
| Calliditas Therapeutics US Inc. | 37 | $31K |
| Travere Therapeutics, Inc. TVTX | 14 | $10K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $2,112 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $408 |
| ZOLL Medical Corporation | 1 | $358 |
| Vantive US Healthcare LLC | 1 | $72.54 |
| NxStage Medical, Inc. | 1 | $19.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.